Drug Topics

SEPTEMBER 19, 2024

Following the Federal Trade Commission’s interim report on PBMs, legislators are galvanized to make change happen.

210

210

STAT

SEPTEMBER 19, 2024

GLP-1 based drugs are transforming the treatment of obesity and opening up new avenues for addressing heart disease , addiction , and even Alzheimer’s. Now, three scientists who played key roles in their invention have won a prestigious Lasker Award for biomedical research.  Announced on Thursday in New York, the Lasker-DeBakey Clinical Medical Research Award will be shared by Svetlana Mojsov and Joel Habener , who identified and characterized the GLP-1 hormone in the 1980s whil

Pharmaceutical Companies 145

Pharmaceutical Companies Pharmaceutical Companies Hospitals 145

Pharmacy Times

SEPTEMBER 19, 2024

These pharmacies address cost, understanding, and safety concerns through high-touch support and coordination.

Specialty Pharmacies 139

Specialty Pharmacies 139

STAT

SEPTEMBER 19, 2024

On Tuesday, the Centers for Disease Control and Prevention, the Centers for Medicare and Medicaid Services, and the Agency for Healthcare Research and Quality took an important step: They launched the Core Elements of Hospital Diagnostic Excellence , a new project to help reduce the number of Americans who die or are permanently disabled each year by diagnostic error.

Hospitals 138

Hospitals 138

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

Fierce Healthcare

SEPTEMBER 19, 2024

Major Indiana managed care organizations and health systems are blamed for defrauding the state Medicaid system by tens, if not hundreds, of millions of dollars, says a newly unsealed whistleblower | A newly unsealed lawsuit alleges major health insurers and health systems defrauded Indiana Medicaid by hundreds of millions of dollars, with the government office likely influenced by corporate lobbying.

Insurance 137

Insurance Hospitals 137

STAT

SEPTEMBER 19, 2024

Amid layoffs and a disintegrating share price, former investor darling Ginkgo Bioworks is trying out a new tack to find customers. The biotech this week announced a new artificial intelligence model for use in biological research, as well as a data service academic researchers and companies can use to develop their own models. The announcement comes as a growing number of biotechs, big tech companies, and academics apply neural networks and machine learning to biology, promising that the same ba

136

136

Pharmacy Times

SEPTEMBER 19, 2024

Results displayed a non-inferior immune response of the co-administered vaccines, compared to administration in individual visits.

Vaccines 132

Vaccines Immunization 132

Fierce Healthcare

SEPTEMBER 19, 2024

Health tech startup Dandelion Health launched a clinical artificial intelligence marketplace that merges third-party algorithms and Dandelion's data platform and model validation capabilities | Through a new solution, Dandelion Health can bring together AI developers and life sciences companies to answer questions in a fraction of the time as a randomized controlled trial.

131

131

STAT

SEPTEMBER 19, 2024

Check out STAT’s exclusive breakthrough devices tracker.  The latest medical devices to receive breakthrough status from the Food and Drug Administration range across conditions, with several treating cardio and neurovascular conditions.  The FDA’s breakthrough devices program is designed to speed the path to market for novel, potentially lifesaving products.

FDA 130

FDA 130

Fierce Pharma

SEPTEMBER 19, 2024

A study from The BMJ indicates that the newest class of migraine drugs—which includes Pfizer’s Nurtec, AbbVie’s Ubrelvy and Eli Lilly’s Reyvow—is less effective in the acute treatment of migra | A study from The BMJ indicates that the newest class of migraine drugs—which includes Pfizer’s Nurtec, AbbVie’s Ubrelvy and Eli Lilly’s Reyvow—is less effective in the acute treatment of migraines than a previous class of medicines.

129

129

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

STAT

SEPTEMBER 19, 2024

Serial biotech founder George Church has a new startup, and this time, he has skin in the game, quite literally.  Church, the enigmatic founder behind companies including eGenesis , Editas Medicine, and Colossal Biosciences , donated some of his own skin cells for use at his new startup GC Therapeutics. (And yes, the letters in the company’s name stand for “George Church.

Immunization 129

Immunization 129

Fierce Pharma

SEPTEMBER 19, 2024

From truckloads of torn documents to avian incursions in the production plant, Granules India’s recent manufacturing reprimand from the FDA is alarming no matter which way you look at it. | Earlier this month, Granules was slapped with a Form 483 following an inspection of its Telangana facility in India that ran from Aug. 26 to Sept. 6. The FDA’s report cites six observations around poor quality control procedures, subpar cleaning, cross-contamination risks and more.

Documentation 128

Documentation FDA 128

Fierce Healthcare

SEPTEMBER 19, 2024

The Senate Committee on Health, Education, Labor and Pensions voted unanimously Thursday morning to bring civil enforcement and a criminal contempt charge against Steward Health CEO Ralph de la Tor | Ralph de la Torre, M.D., invoked the Fifth Amendment in his refusal to appear before Congress. Sens. Sanders and Cassidy said that he must invoke that right in person and in response to specific questions during testimony.

127

127

STAT

SEPTEMBER 19, 2024

NEW YORK — Nearly two decades ago, European regulators pulled an obesity drug called rimonabant off the market due to concerns it was tied to suicidal ideation. Now, a small handful of companies are developing drugs that use a similar approach to the discarded treatment, which involves inhibiting type 1 cannabinoid receptors, or CB1 receptors.

125

125

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Pharmacy Times

SEPTEMBER 19, 2024

Jenni Zilka discusses the growing issue of "pharmacy deserts" and the need to maintain the financial viability of pharmacies.

123

123

STAT

SEPTEMBER 19, 2024

A group of lawmakers wants the U.S. Patent & Trademark Office and drug companies to change their approach toward handling mistakes in disclosing patent terms, because the errors can be exploited in ways that thwart competition and, ultimately, raise the cost of medicines. The problem cited by the lawmakers concerns the way that administrative delays are handled at the PTO.

Pharmaceutical Companies 118

Pharmaceutical Companies Pharmaceutical Companies 118

Pharmacy Times

SEPTEMBER 19, 2024

Though hospitalizations and test positivity remain at modest levels, wastewater analysis indicates high circulation of SARS-CoV-2, especially in western states.

Hospitals 122

Hospitals 122

Drug Topics

SEPTEMBER 19, 2024

Johnny Garcia, Senior Director of Policy at the Pharmaceutical Care Management Association, discussed ongoing issues within the pharmaceutical supply chain and his organization’s role within it.

112

112

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Pharmacy Times

SEPTEMBER 19, 2024

Patients with for HER2-positive breast cancer have an increased risk of developing brain tumors.

121

121

Drug Topics

SEPTEMBER 19, 2024

Compounded with lifestyle interventions, researchers compared liraglutide with a placebo to measure its efficacy amongst children under 12 years old.

Compounding 112

Compounding 112

pharmaphorum

SEPTEMBER 19, 2024

Neuralink gets FDA breakthrough status for an implantable chip called Blindsight that promises to restore eyesight to the blind

FDA 111

FDA 111

STAT

SEPTEMBER 19, 2024

You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences.  Sign up to get it  delivered in your inbox every Tuesday and Thursday. Talkspace offers therapy through Amazon now As virtual mental health company Talkspace aims to grow its business, it’s added a very large entry point to the top of its funnel.

Insurance 111

Insurance 111

pharmaphorum

SEPTEMBER 19, 2024

FDA turns down Vanda Pharma's tradipitant for gastroparesis, prompting a furious response from the company

FDA 111

FDA 111

STAT

SEPTEMBER 19, 2024

In June, a clinical trial showed that a twice-yearly injection was just as effective at preventing HIV as the daily oral medication. The trial  was so successful  that the Data Monitoring Committee instructed researchers to halt the study and immediately offer the injection to all study participants.  This is just the most recent development in longer-acting HIV medications, which have become a transformative force in the journey toward ending the HIV/AIDS crisis.

107

107

pharmaphorum

SEPTEMBER 19, 2024

ICER will preempt the next Medicare drug pricing round with a 'special report' on two COPD drugs from GSK

111

111

Fierce Pharma

SEPTEMBER 19, 2024

Gilead Sciences’ Kite Pharma will sell its stake in China’s Fosun Kite Biotechnology nearly eight years after forming the 50-50 cell-therapy-focused joint venture with Fosun Pharma. | Gilead Sciences’ Kite Pharma will sell its stake in China’s Fosun Kite Biotechnology nearly eight years after forming the cell therapy-focused joint venture with Fosun Pharma.

105

105

Pharmaceutical Technology

SEPTEMBER 19, 2024

An innovative approach to healthcare, precision medicine is a new medical model that takes into account individual differences in genes, environments, and lifestyles to drive better outcomes through medicine.

105

105

STAT

SEPTEMBER 19, 2024

Amid ongoing concern over the quality of medicines made in India, a major supplier of generic medicines was seen removing three truckloads of “scrap materials” from a facility that was being inspected last month by the Food and Drug Administration. Specifically, a “large number of torn pieces” of documents that should have been kept to verify manufacturing and testing practices were found in the trucks, as well as in a scrap bag at a site run by Granules in Telangana,

Documentation 105

Documentation FDA Generic Medicine 105

pharmaphorum

SEPTEMBER 19, 2024

Upstream Bio has become the latest biotech to chance its arm with a public listing in the US, seeking funds for its rival to respiratory drug Tezspire.

105

105

Pharmacy Times

SEPTEMBER 19, 2024

Luspatercept reduced the need for transfusion in patients with myelofibrosis (MF).

101

101

STAT

SEPTEMBER 19, 2024

Are generalist investors good or bad for biotech? How did Elaine and Adam’s trip to New York go? And how long has George Church owned that brown corduroy blazer? We cover all that and more on the latest episode of “The Readout Loud.” Mizuho analyst Jared Holz joins us to discuss what the Federal Reserve’s long-awaited decision to lower interest rates means for biotech stocks and startups.

101

101

Pharmacy Times

SEPTEMBER 19, 2024

Seroconversion was observed in 95.8% of participants but dropped to 75.6% at the 4-year follow-up.

Vaccines 101

Vaccines 101

Fierce Pharma

SEPTEMBER 19, 2024

Respiratory medicine is one frontier of the global healthcare landscape which has undergone significant transformations in recent years. | AstraZeneca's Maria Belvisi explores innovative approaches in respiratory medicine, from AI-driven trials to next-gen therapeutics.

98

98